
Healthcare & Pharmaceuticals · NSE
JFL Life Sciences Limited, established in 2010, is a pharmaceutical company specializing in the manufacturing of a variety of medicines. Its product range includes dry powder injections (B-Lactam), tablets, capsules (B-Lactam and general), and oral rehydration solutions (ORS). The company follows a bulk sales strategy, supplying its products to pharmaceutical marketers and traders who then distribute them to customers. JFL has a strong presence across India and exports to 10 countries worldwide. Internationally, JFL supplies products to African, Middle Eastern, and CIS countries through merchant exporters. The company is also registered with the Ministries of Health (MOH) in Kenya, Nigeria, Yemen, Cambodia, and Myanmar for specific products, with additional registrations in Ukraine, Uzbekistan, and Kazakhstan. JFL operates two leased manufacturing units in Gujarat to produce its pharmaceutical products.
Price Band
₹61
Issue Size
₹18.17 Cr
Lot Size
2000 shares
GMP
Est. Listing
₹61
at current GMP
Subscribed
8.93x
overall
Open
25 Aug 2022
Close
30 Aug 2022
Allotment
6 Sep 2022
Refund
7 Sep 2022
Demat Credit
8 Sep 2022
Listing
8 Sep 2022